Literature DB >> 30911217

Respiratory Tract Colonization by Candida species Portends Worse Outcomes in Immunocompromised Patients.

Kathryn M Pendleton1, Robert P Dickson2, Duane W Newton3, Timothy C Hoffman4, Gregory A Yanik5, Gary B Huffnagle2,6,7,8.   

Abstract

BACKGROUND: The significance and clinical management of Candida colonization of the respiratory tract are ill-defined. We now report the frequency of Candida species from the lower respiratory tract in hematopoietic stem cell transplant recipients (HSCT) undergoing bronchoscopy with broncheoalveolar lavage (BAL) for pneumonitis post-HSCT.
METHODS: The University of Michigan Clinical Microbiology Lab Database was queried for all respiratory cultures positive for Candida species between 2000-2012. We concurrently performed a retrospective analysis of 515 HSCT recipients with pneumonitis at our institution between 2001-2012.
RESULTS: During this twelve-year period, there were 2524 unique Candida isolates (78% Candida albicans). Of the 515 HSCT patients with suspected pneumonitis,127 (24.7%) HSCT subjects were culture positive for a fungal pathogen, with Candida species identified in 27 cases (5.2%). When compared with other HSCT subjects, those cultures positive for Candida had significantly increased mortality (p=0.04).
CONCLUSIONS: Candida sp. are commonly cultured from the respiratory tract of HSCT recipients, with increased mortality in affected patients. While there is insufficient evidence for anti-fungal treatment of Candida species colonization, the presence of the yeast may be useful as a surrogate marker of disease severity.

Entities:  

Keywords:  Candida; Hematopoietic Stem Cell Transplant; Respiratory Tract Colonization

Year:  2018        PMID: 30911217      PMCID: PMC6430131          DOI: 10.1097/CPM.0000000000000279

Source DB:  PubMed          Journal:  Clin Pulm Med        ISSN: 1068-0640


  34 in total

1.  The significance of Candida albicans in human sputum.

Authors:  G L BAUM
Journal:  N Engl J Med       Date:  1960-07-14       Impact factor: 91.245

2.  Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.

Authors:  Kaaren G Vargas; Sophie Joly
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematological malignancies.

Authors:  A Safdar; D Armstrong
Journal:  Bone Marrow Transplant       Date:  2002-12       Impact factor: 5.483

4.  Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia.

Authors:  Elie Azoulay; Jean-François Timsit; Muriel Tafflet; Arnaud de Lassence; Michael Darmon; Jean-Ralph Zahar; Christophe Adrie; Maité Garrouste-Orgeas; Yves Cohen; Bruno Mourvillier; Benoît Schlemmer
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

5.  Pulmonary candidiasis in patients with cancer: an autopsy study.

Authors:  D P Kontoyiannis; B T Reddy; H A Torres; M Luna; R E Lewis; J Tarrand; G P Bodey; I I Raad
Journal:  Clin Infect Dis       Date:  2001-12-17       Impact factor: 9.079

6.  Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

Authors:  K A Marr; K Seidel; T C White; R A Bowden
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

7.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

Authors:  J L Goodman; D J Winston; R A Greenfield; P H Chandrasekar; B Fox; H Kaizer; R K Shadduck; T C Shea; P Stiff; D J Friedman
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

8.  The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients.

Authors:  Marie-Soleil Delisle; David R Williamson; Marc M Perreault; Martin Albert; Xuran Jiang; Daren K Heyland
Journal:  J Crit Care       Date:  2008-03       Impact factor: 3.425

9.  Practices in non-neutropenic ICU patients with Candida-positive airway specimens.

Authors:  Elie Azoulay; Yves Cohen; Jean-Ralph Zahar; Maité Garrouste-Orgeas; Christophe Adrie; Pierre Moine; Arnaud de Lassence; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

10.  Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study.

Authors:  Saad Nseir; Elsa Jozefowicz; Béatrice Cavestri; Boualem Sendid; Christophe Di Pompeo; Florent Dewavrin; Raphaël Favory; Micheline Roussel-Delvallez; Alain Durocher
Journal:  Intensive Care Med       Date:  2006-11-08       Impact factor: 17.440

View more
  6 in total

1.  Clinical Implication of Candida Score in Multidrug-Resistant Pneumonia with Airway Candida Colonization.

Authors:  Yeonju La; Da Eun Kwon; Soyoung Jeon; Sujee Lee; Kyoung Hwa Lee; Sang Hoon Han; Young Goo Song
Journal:  Infect Chemother       Date:  2022-05-13

2.  Pulmonary Microbial Composition in Sepsis-Induced Acute Respiratory Distress Syndrome.

Authors:  Peng Zhang; Baoyi Liu; Weihao Zheng; Yantang Chen; Zhentao Wu; Yuting Lu; Jie Ma; Wenjie Lu; Mingzhu Zheng; Wanting Wu; Zijie Meng; Jinhua Wu; Yan Zheng; Xin Zhang; Shuang Zhang; Yanming Huang
Journal:  Front Mol Biosci       Date:  2022-06-23

3.  Identification of Cryptic Species of Four Candida Complexes in a Culture Collection.

Authors:  Gustavo Fontecha; Kathy Montes; Bryan Ortiz; Celeste Galindo; Sharleen Braham
Journal:  J Fungi (Basel)       Date:  2019-12-17

Review 4.  Anticandidal Activities by Lactobacillus Species: An Update on Mechanisms of Action.

Authors:  Roberto Vazquez-Munoz; Anna Dongari-Bagtzoglou
Journal:  Front Oral Health       Date:  2021-07-16

5.  Plasma 1,3-β-d-glucan levels predict adverse clinical outcomes in critical illness.

Authors:  Georgios D Kitsios; Daniel Kotok; Haopu Yang; Malcolm A Finkelman; Yonglong Zhang; Noel Britton; Xiaoyun Li; Marina S Levochkina; Amy K Wagner; Caitlin Schaefer; John J Villandre; Rui Guo; John W Evankovich; William Bain; Faraaz Shah; Yingze Zhang; Barbara A Methé; Panayiotis V Benos; Bryan J McVerry; Alison Morris
Journal:  JCI Insight       Date:  2021-07-22

Review 6.  Insights From the Lactobacillus johnsonii Genome Suggest the Production of Metabolites With Antibiofilm Activity Against the Pathobiont Candida albicans.

Authors:  Roberto Vazquez-Munoz; Angela Thompson; Jordan T Russell; Takanori Sobue; Yanjiao Zhou; Anna Dongari-Bagtzoglou
Journal:  Front Microbiol       Date:  2022-03-07       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.